GLYCOSYLATED HEMOGLOBIN HBA1C AS A BIOMARKER FOR DIABETIC RETINOPATHY

S FATIMA; S ASHRAF; A TAHIR; A BATOOL; I LATIF; I AMEEN

doi:10.54112/bcsrj.v2024i1.717

Authors

S FATIMA University of Sialkot, Sialkot, Pakistan
S ASHRAF University of Sialkot, Sialkot, Pakistan
A TAHIR University of Sialkot, Sialkot, Pakistan
A BATOOL University of Narowal, Narowal, Pakistan
I LATIF University of Sialkot, Sialkot, Pakistan
I AMEEN University of Sialkot, Sialkot, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.717

Keywords:

Hyperglycemia, Diabetes Mellitus, Retinopathy, Metabolic Disorders, Microvascular Disorders

Abstract

: Diabetes Mellitus (DM) is a long-term metabolic disorder marked by hyperglycemia. Diabetes may lead to various complications like retinopathy. Diabetic retinopathy is a microvascular disorder that may lead to vision loss. It was a hospital-based study to determine the prevalence of diabetic retinopathy in chronic diabetic patients. Patients who visited DHQ and Al Sheikh Hospital Sialkot with blurry or poor vision were taken as samples. The sample size for this study was 100. The demographic and medical history of patients were taken through a questionnaire. These patients were checked by an experienced ophthalmologist after the pupil dilation. After the proper examination, it was suggested that a patient have an HbA1c test to monitor diabetic control. The HbA1c test is one of the most effective techniques to monitor diabetic control. Out of the 100 patients, 60% were diagnosed with diabetic retinopathy. Out of these, 36% were diagnosed with non-proliferative diabetic retinopathy, and 24% were diagnosed with proliferative retinopathy. The results were quite alarming, as 60 out of 100 were suffering from diabetic retinopathy. This study provided the prevalence of diabetic retinopathy in the district of Sialkot. This study also helps to understand the severity of hyperglycemia that may lead to vision loss due to diabetic retinopathy.

Downloads

Download data is not yet available.

References

Al Slail, F. Y., Abid, O., Assiri, A. M., Memish, Z. A., & Ali, M. K. (2016). Cardiovascular risk profiles of adults with type-2 diabetes treated at urban hospitals in Riyadh, Saudi Arabia. Journal of epidemiology and global health, 6(1), 29–36.

Alemu Mersha, G., Alimaw, Y. A., & Woredekal, A. T. (2022). Prevalence of diabetic retinopathy among diabetic patients in Northwest Ethiopia—A cross-sectional hospital-based study. PLoS One, 17(1), e0262664.

Badedi, M., Solan, Y., Darraj, H., Sabai, A., Mahfouz, M., Alamodi, S., & Alsabaani, A. (2016). Factors associated with long-term control of type 2 diabetes mellitus.

Journal of diabetes research, 2016. Chaturvedi, N. (2007). The burden of diabetes and its complications: trends and implications for intervention. Diabetes research and clinical practice, 76(3), S3-S12.

Corcóstegui, B., Durán, S., González-Albarrán, M. O., Hernández, C., Ruiz-Moreno, J. M., Salvador, J., . . . Simó, R. (2017). Update on diagnosis and treatment of diabetic retinopathy: a consensus guideline of the working group of ocular health (Spanish Society of Diabetes and Spanish Vitreous and Retina Society)—Journal of Ophthalmology, 2017.

Din, J.-u., Qureshi, M. B., Khan, A. J., Khan, M. D., & Ahmed, K. (2006). Prevalence of diabetic retinopathy among individuals screened positive for diabetes in five community-based eye camps in northern Karachi, Pakistan. J Ayub Med Coll Abbottabad, 18(3), 40.

Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014). Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes research and clinical practice, 103(2), 137–149.

Ibrahim, M. (2017). Impact of Age, Duration, and Control of Diabetes on Risk of Diabetic Retinopathy among Sudanese Diabetic Patients in Khartoum, Sudan- 2016: Hospital-based Cross-Sectional study. International Journal of Sciences: Basic and Applied Research (IJSBAR), 33(1), 68–75.

Kebede, S. A., Tessema, Z. T., Balcha, S. A., & Ayele, T. A. (2022). Joint modeling of time to diabetic retinopathy and change in fasting blood sugar among type 2 diabetic patients, Northwest Ethiopia. Scientific reports, 12(1), 1-9.

Kharroubi, A., & Darwish, H. (2015). Diabetes mellitus: The epidemic of the century. World J Diabetes 6 (6): 850–867. In.

Klein, R., Klein, B. E., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984). The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when the age at diagnosis is less than 30 years. Archives of ophthalmology, 102(4), 520-526.

Nakagami, T., Takahashi, K., Suto, C., Oya, J., Tanaka, Y., Kurita, M., . . . Uchigata, Y. (2017). Diabetes diagnostic thresholds of the glycated hemoglobin A1c and fasting plasma glucose levels considering the 5-year incidence of retinopathy. Diabetes research and clinical practice, 124, 20-29.

Organization, W. H. (2011). Use of glycated hemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. Retrieved from Organization, W. H. (2019). Classification of diabetes mellitus.

Rogers, S. L., McIntosh, R. L., Lim, L., Mitchell, P., Cheung, N., Kowalski, J. W., . . . Wong, T. Y. (2010). Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology, 117(6), 1094–1101. e1095. Sayin, N., Kara, N., & Pekel, G. (2015). Ocular complications of diabetes mellitus.

World journal of diabetes, 6(1), 92. Sierra, G. (2009). The global pandemic of diabetes. African Journal of Diabetes Medicine, 17(11), 4–8.

Stratton, I., Kohner, E., Aldington, S., Turner, R., Holman, R., Manley, S., & Matthews, D. (2001). UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over six years from diagnosis. Diabetologia, 44(2), 156-163.

Stratton, I. M., Adler, A. I., Neil, H. A. W., Matthews, D. R., Manley, S. E., Cull, C. A., . . . Holman, R. R. (2000). Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): a prospective observational study. Bmj, 321(7258), 405-412.

Tripathy, D., Merovci, A., Basu, R., Abdul-Ghani, M., & DeFronzo, R. A. (2019). Mild physiologic hyperglycemia induces hepatic insulin resistance in healthy, regular glucose-tolerant participants. The Journal of Clinical Endocrinology & Metabolism, 104(7), 2842–2850.

Varma, R., Macias, G. L., Torres, M., Klein, R., Peña, F. Y., Azen, S. P., & Group, L.

A. L. E. S. (2007). Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study. Ophthalmology, 114(7), 1332–1340.

Vision, W. (2020). The Right to Sight, Global Initiative for Eliminating Avoidable Blindness: Action Plan 2006–2011. Geneva: World Health Organization, 207.

Yau, J. W., Rogers, S., Kawasaki, R., Lamoureux, E., Kowalski, J., Bek, T., . . . Grauslund, J. (2012a). 148 Bibliography MS Roy, T. Sharma, J. Shaw, H. Taylor, JM Tielsch, R. Varma, JJ Wang, N. Wang, S. West, L. Xu, M. Yasuda, X. Zhang, P. Mitchell, TY Wong, and for the Meta-Analysis for Eye Disease (META-EYE) Study Group, “Global Prevalence and Major Risk Factors of Diabetic Retinopathy,” Diabetes Care, 35(3), 556-564.

Yau, J. W., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T.,Grauslund, J. (2012b). Global prevalence and major risk factors of diabetic retinopathy. Diabetes care, 35(3), 556-564.

Zheng, Y., He, M., & Congdon, N. (2012). The worldwide epidemic of diabetic retinopathy. Indian journal of ophthalmology, 60(5), 428.

Zheng, Y., Lamoureux, E. L., Lavanya, R., Wu, R., Ikram, M. K., Wang, J. J., . . . Saw, S.-M. (2012). Prevalence and risk factors of diabetic retinopathy in migrant Indians in an urbanized society in Asia: the Singapore Indian eye study. Ophthalmology, 119(10), 2119-2124